Close Brothers shares drop 5% following RBC downgrade over motor finance fears

Close Brothers shares fell more than 5% after RBC downgraded the stock to "sector perform" from "outperform" and cut its price target to 470p from 625p, citing renewed uncertainty around the UK motor finance redress scheme. RBC expects the judicial review process to push a hearing to Dec 2026–Feb 2027 (later than the FCA’s prior expectation) and flagged potential value drag, removing a previously forecast 5p dividend and estimating provisions could represent ~230 bps of core Tier 1 capital (~£200m of a £320m provision). The broker also warned scrap/downsides could imply sizable administrative and litigation impacts (with FCA’s estimate of £6.3bn incremental lender admin costs and risks including net interest margin pressure and a UK recession).

Analysis

The market is still underpricing how much of this story is about capital optionality, not just the eventual cash cost of redress. Even if the provision is broadly sufficient, the overhang forces CBGPF to run with a permanently higher cost of equity, weaker dividend capacity, and less flexibility to grow risk-weighted assets; that is a multiple problem that can persist well before any final legal ruling.

Second-order, the longer timetable is not benign: a 2026-27 process keeps management trapped in balance-sheet conservation mode while competitors with cleaner conduct profiles can take share in SME and specialist lending. That is especially relevant if UK credit conditions soften, because the market will penalize any incremental default drift far more harshly in a name already carrying conduct uncertainty.

The contrarian miss is that a delayed hearing does not necessarily mean a worse end-loss; it may simply extend the duration of the discount. The stock can drift lower without a fresh negative headline if the board cannot credibly restart capital returns, so the real catalyst is not the tribunal date but whether FY26 results come with a resumed dividend or a larger-than-expected capital buffer. Thesis is weakened if the FCA scope narrows materially, or if management reaffirms distributions with CET1 comfortably above target despite the process.

Key Decisions for Investors

• Short CBGPF on strength or add on any relief rally toward 470p-500p; target a drift lower over 1-3 months as dividend optionality gets pushed out. Falsify if management restores a dividend and guides to stable capital generation at FY26 results.
• Pair trade: long LYG or BARC vs short CBGPF for 6-12 month relative value. The long leg has far less conduct overhang, while the short leg remains exposed to a cost-of-equity reset and recurring legal uncertainty.
• Buy CBGPF downside via put spread into the next earnings/event window if options liquidity permits; structure for a 2-4x payoff if the market begins pricing a missed dividend and weaker capital return path. If options are illiquid, use a small equity short with a hard stop above the prior downgrade-driven gap level.
• Watch for any FCA narrowing of the complaints-led process or evidence that the provision can be released; that is the main catalyst that could force a re-rating, but absent that, the stock is a candidate to underperform UK financials over the next 3-6 months.